Common Contracts

45 similar Common Stock contracts by Homology Medicines, Inc., Seres Therapeutics, Inc., Adverum Biotechnologies, Inc., others

ATARA BIOTHERAPEUTICS, INC. COMMON STOCK SALES AGREEMENT
Common Stock • November 1st, 2023 • Atara Biotherapeutics, Inc. • Biological products, (no disgnostic substances) • New York

Atara Biotherapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:

AutoNDA by SimpleDocs
CUE HEALTH INC. COMMON STOCK SALES AGREEMENT
Common Stock • August 9th, 2023 • Cue Health Inc. • Laboratory analytical instruments • New York

Cue Health Inc., a Delaware corporation, (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:

SERES THERAPEUTICS, INC. COMMON STOCK SALES AGREEMENT
Common Stock • August 8th, 2023 • Seres Therapeutics, Inc. • Pharmaceutical preparations • New York
AN2 THERAPEUTICS, INC. COMMON STOCK SALES AGREEMENT
Common Stock • April 6th, 2023 • AN2 Therapeutics, Inc. • Pharmaceutical preparations • New York
HOMOLOGY MEDICINES, INC. COMMON STOCK SALES AGREEMENT
Common Stock • March 9th, 2023 • Homology Medicines, Inc. • Pharmaceutical preparations • New York
IO BIOTECH, INC. COMMON STOCK SALES AGREEMENT
Common Stock • February 15th, 2023 • IO Biotech, Inc. • Pharmaceutical preparations • New York
23ANDME HOLDING CO. COMMON STOCK SALES AGREEMENT
Common Stock • February 6th, 2023 • 23andMe Holding Co. • Pharmaceutical preparations • New York
EVELO BIOSCIENCES, INC. COMMON STOCK SALES AGREEMENT
Common Stock • July 1st, 2022 • Evelo Biosciences, Inc. • Pharmaceutical preparations • New York
KYMERA THERAPEUTICS, INC. COMMON STOCK SALES AGREEMENT
Common Stock • October 1st, 2021 • Kymera Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York

Kymera Therapeutics, Inc. (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:

SERES THERAPEUTICS, INC. COMMON STOCK SALES AGREEMENT
Common Stock • May 21st, 2021 • Seres Therapeutics, Inc. • Pharmaceutical preparations • New York
ADVERUM BIOTECHNOLOGIES, INC. COMMON STOCK SALES AGREEMENT
Common Stock • December 17th, 2020 • Adverum Biotechnologies, Inc. • Biological products, (no disgnostic substances) • New York

Adverum Biotechnologies, Inc. (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:

HOMOLOGY MEDICINES, INC. COMMON STOCK SALES AGREEMENT
Common Stock • March 12th, 2020 • Homology Medicines, Inc. • Pharmaceutical preparations • New York
MACROGENICS, INC. COMMON STOCK SALES AGREEMENT
Common Stock • December 23rd, 2019 • Macrogenics Inc • Pharmaceutical preparations • New York

MacroGenics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:

SERES THERAPEUTICS, INC. COMMON STOCK SALES AGREEMENT
Common Stock • November 27th, 2019 • Seres Therapeutics, Inc. • Pharmaceutical preparations • New York
GRITSTONE ONCOLOGY, INC. COMMON STOCK SALES AGREEMENT
Common Stock • October 15th, 2019 • Gritstone Oncology, Inc. • Biological products, (no disgnostic substances) • New York

Gritstone Oncology, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:

SUTRO BIOPHARMA, INC. COMMON STOCK SALES AGREEMENT
Common Stock • October 4th, 2019 • Sutro Biopharma, Inc. • Biological products, (no disgnostic substances) • New York
MAGENTA THERAPEUTICS, INC. COMMON STOCK SALES AGREEMENT
Common Stock • August 8th, 2019 • Magenta Therapeutics, Inc. • Pharmaceutical preparations • New York

Magenta Therapeutics, Inc. (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:

OTONOMY, INC. COMMON STOCK SALES AGREEMENT
Common Stock • August 1st, 2019 • Otonomy, Inc. • Pharmaceutical preparations • New York
AVROBIO, INC. COMMON STOCK SALES AGREEMENT
Common Stock • July 1st, 2019 • AVROBIO, Inc. • Biological products, (no disgnostic substances) • New York
APTINYX INC. COMMON STOCK SALES AGREEMENT
Common Stock • July 1st, 2019 • Aptinyx Inc. • Pharmaceutical preparations • New York
EVELO BIOSCIENCES, INC. COMMON STOCK SALES AGREEMENT
Common Stock • June 3rd, 2019 • Evelo Biosciences, Inc. • Pharmaceutical preparations • New York

The Company has filed or will file, in accordance with the provisions of the Securities Act of 1933, as amended, and the rules and regulations thereunder (collectively, the "Securities Act"), with the Commission a registration statement on Form S-3, including (a) a base prospectus, relating to certain securities, including the Common Stock, to be issued from time to time by the Company, and which incorporates by reference documents that the Company has filed or will file in accordance with the provisions of the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (collectively, the "Exchange Act") and (b) a prospectus supplement specifically relating to the Placement Shares (the "Prospectus Supplement") to the base prospectus included as part of such registration statement. The Company has furnished to Cowen, for use by Cowen, copies of the prospectus included as part of such registration statement, as supplemented by the Prospectus Supplement, relating

UNITY BIOTECHNOLOGY, INC. $75,000,000 SHARES OF COMMON STOCK SALES AGREEMENT
Common Stock • June 3rd, 2019 • Unity Biotechnology, Inc. • Pharmaceutical preparations • New York

Unity Biotechnology, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:

AutoNDA by SimpleDocs
UNUM THERAPEUTICS INC. COMMON STOCK SALES AGREEMENT
Common Stock • April 2nd, 2019 • Unum Therapeutics Inc. • Pharmaceutical preparations • New York
HOMOLOGY MEDICINES, INC. COMMON STOCK SALES AGREEMENT
Common Stock • April 1st, 2019 • Homology Medicines, Inc. • Pharmaceutical preparations • New York
HTG MOLECULAR DIAGNOSTICS, INC. COMMON STOCK SALES AGREEMENT
Common Stock • March 13th, 2019 • HTG Molecular Diagnostics, Inc • Laboratory analytical instruments • New York

HTG Molecular Diagnostics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:

CHIASMA, INC. COMMON STOCK SALES AGREEMENT
Common Stock • November 8th, 2018 • Chiasma, Inc • Pharmaceutical preparations • New York
CTI BIOPHARMA CORP. COMMON STOCK SALES AGREEMENT
Common Stock • November 1st, 2018 • Cti Biopharma Corp • Pharmaceutical preparations • New York

CTI BioPharma Corp., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:

INVITAE CORPORATION COMMON STOCK SALES AGREEMENT
Common Stock • August 10th, 2018 • Invitae Corp • Services-medical laboratories • New York

Invitae Corporation, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:

SIENNA BIOPHARMACEUTICALS, INC. COMMON STOCK SALES AGREEMENT
Common Stock • August 3rd, 2018 • Sienna Biopharmaceuticals, Inc. • Pharmaceutical preparations • New York

Sienna Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:

DICERNA PHARMACEUTICALS, INC. COMMON STOCK SALES AGREEMENT
Common Stock • May 17th, 2018 • Dicerna Pharmaceuticals Inc • Pharmaceutical preparations • New York

Dicerna Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:

RECRO PHARMA, INC. COMMON STOCK SALES AGREEMENT
Common Stock • December 29th, 2017 • Recro Pharma, Inc. • Pharmaceutical preparations • New York
ANTARES PHARMA, INC. COMMON STOCK SALES AGREEMENT
Common Stock • August 11th, 2017 • Antares Pharma, Inc. • Surgical & medical instruments & apparatus • New York
ADVERUM BIOTECHNOLOGIES, INC. COMMON STOCK SALES AGREEMENT
Common Stock • August 10th, 2017 • Adverum Biotechnologies, Inc. • Biological products, (no disgnostic substances) • New York

Adverum Biotechnologies, Inc. (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:

VERSARTIS, INC. COMMON STOCK SALES AGREEMENT
Common Stock • August 10th, 2017 • Versartis, Inc. • Pharmaceutical preparations • New York

Versartis, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:

CALITHERA BIOSCIENCES, INC. COMMON STOCK SALES AGREEMENT
Common Stock • August 8th, 2017 • Calithera Biosciences, Inc. • Pharmaceutical preparations • New York

Calithera Biosciences, Inc. (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:

Time is Money Join Law Insider Premium to draft better contracts faster.